TAKEDA PHARMACEUTICALS CO innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	332
#2	Australia	286
#3	EPO (European Patent Office)	255
#4	Canada	191
#5	WIPO (World Intellectual Property Organization)	168
#6	Brazil	102
#7	Taiwan	91
#8	Chile	82
#9	China	75
#10	Argentina	67
#11	Israel	65
#12	Republic of Korea	57
#13	South Africa	51
#14	Mexico	49
#15	Singapore	40
#16	Tunisia	39
#17	EAPO (Eurasian Patent Organization)	37
#18	Philippines	35
#19	Hong Kong	33
#20	Hungary	33
#21	Serbia	30
#22	Ukraine	30
#23	Jordan	28
#24	Colombia	27
#25	Montenegro	27
#26	Peru	26
#27	Costa Rica	18
#28	Ecuador	16
#29	Morocco	16
#30	Norway	16
#31	Malaysia	15
#32	Dominican Republic	13
#33	Georgia	9
#34	Uruguay	8
#35	United Kingdom	7
#36	New Zealand	4
#37	Netherlands	3
#38	Belgium	2
#39	Czechia	2
#40	Saudi Arabia	2
#41	Slovenia	2
#42	Russian Federation	1

#	Technology
#1	Therapeutic chemical compounds
#2	Medical preparations
#3	Heterocyclic compounds
#4	Peptides
#5	Microorganisms
#6	Acyclic or carbocyclic compounds
#7	Organic chemistry methods
#8	Special acyclic compounds
#9	Unspecified technologies
#10	Analysing materials

Publication	Filing date	Title
WO2021079874A1	2020-10-20	Proliferation inhibitor
WO2021075476A1	2020-10-15	Heterocyclic compound
WO2021065877A1	2020-09-29	Quantitative pcr method and kit therefor
WO2021059017A1	2020-09-25	Heterocyclic compound and use thereof
WO2021060567A1	2020-09-24	2-isoindol-1,3,4-oxadiazole derivatives useful as hdac6 inhibitors
WO2021055326A1	2020-09-15	Azole-fused pyridazin-3(2h)-one derivatives
WO2021048822A1	2020-09-12	Tak-925 for use in treating narcolepsy
WO2021048821A1	2020-09-12	Use of an orexin 2 receptor agonist for the treatment of excessive sleepiness
WO2021020363A1	2020-07-28	Heterocyclic compound
WO2021020362A1	2020-07-28	Heterocyclic compound
WO2021015294A2	2020-07-17	Combination therapy for cancer treatment
WO2021005541A1	2020-07-09	Administration of sting agonist and checkpoint inhibitors
WO2020262540A1	2020-06-25	Transfection method
WO2020250033A1	2020-06-09	Combination therapies using cd-38 antibodies
WO2020229982A1	2020-05-08	Antibody drug conjugates
WO2020196828A1	2020-03-27	Nitrogen-containing heterocyclic compound
WO2020198053A1	2020-03-20	2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridin-6-yl)-4-methylbenzamide derivatives and similar compounds as ripk2 inhibitors for treating e.g. autoimmune diseases
TW202043196A	2020-01-30	Heterocyclic compound and use thereof
WO2020158762A1	2020-01-29	Heterocyclic compound
WO2020153414A1	2020-01-23	Heterocyclic compound and use thereof